Subscribe to RSS Feed
Medicines-Diabetes Treatment-Micro Labs-Edas-Gomeopharm-Nativa-Berlin-chemie-Haupt Pharma-NovoNordisk-Zentiva-Geropharm-Lilly-Shering-Plau-Pabianice-Lannacher-Torrent-Nizhfarm-ICN-Nanjing-WorwagPharma-Bristol-Myers Squibb-Meda-Wockhardt-AFD-Biocodex-Organics-Hyperion-HiGlance-Vermodje
Ozempic® (Semavik) 0,25/0,5/1 mg/dose solution for subcutaneous administration 3 ml syringe pen 1 pc.
Ozempic is a self-injectable medication that contains the active ingredient, semaglutide. Previously, it has been prescribed ‘off label’ for weight loss, but it is licensed in the UK for treating type 2 diabetes. Semaglutide is available as a weight loss injection under the brand name Semavik.
Medicines-Diabetes Treatment-Micro Labs-Edas-Gomeopharm-Nativa-Berlin-chemie-Haupt Pharma-NovoNordisk-Zentiva-Geropharm-Lilly-Shering-Plau-Pabianice-Lannacher-Torrent-Nizhfarm-ICN-Nanjing-WorwagPharma-Bristol-Myers Squibb-Meda-Wockhardt-AFD-Biocodex-Organics-Hyperion-HiGlance-Vermodje
Currently Shopping by
- The purpose of the medication: Remove This Item Diabetes Treatment
-
Manufacturer:
Micro Labs
Edas
Gomeopharm
Nativa
Berlin-chemie
Haupt Pharma
NovoNordisk
Zentiva
Geropharm
Lilly
Shering-Plau
Pabianice
Lannacher
Torrent
Nizhfarm
ICN
Nanjing
WorwagPharma
Bristol-Myers Squibb
Meda
Wockhardt
AFD
Biocodex
Organics
Hyperion
HiGlance
Vermodje
- The purpose of the medication
- Manufacturer
